Repository logo
 
Publication

Clinical, biochemical and molecular characterization of cystinuria in a cohort of 12 patients.

2012-01Journal article Restricted access
Simple item page
dc.contributor.authorBarbosa, M.
dc.contributor.authorLopes, A.
dc.contributor.authorMota, C.
dc.contributor.authorMartins, E.
dc.contributor.authorOliveira, J.
dc.contributor.authorAlves, S.
dc.contributor.authorDe Bonis, P.
dc.contributor.authorMota, M. do C.
dc.contributor.authorDias, Carlos Matias
dc.contributor.authorRodrigues-Santos, P.
dc.contributor.authorFortuna, A.M.
dc.contributor.authorQuelhas, D.
dc.contributor.authorLacerda, L.
dc.contributor.authorBisceglia, L.
dc.contributor.authorCardoso, M.L.
dc.date.accessioned2012-07-12T17:28:07Z
dc.date.available2012-07-12T17:28:07Z
dc.date.issued2012-01
dc.description.abstractCystinuria is a rare autosomal inherited disorder characterized by impaired transport of cystine and dibasic aminoacids in the proximal renal tubule. Classically, Cystinuria is classified as type I (silent heterozygotes) and non-type I (heterozygotes with urinary hyperexcretion of cystine). Molecularly, Cystinuria is classified as type A (mutations on SLC3A1 gene) and type B (mutations on SLC7A9 gene). The goal of this study is to provide a comprehensive clinical, biochemical and molecular characterization of a cohort of 12 Portuguese patients affected with Cystinuria in order to provide insight into genotype–phenotype correlations. We describe seven type I and five non-type I patients. Regarding the molecular classification, seven patients were type A and five were type B. In SLC3A1 gene, two large genomic rearrangements and 13 sequence variants, including four new variants c.611-2A>C; c.1136+44G>A; c.1597T (p.Y533N); c.*70A>G, were found. One large genomic rearrangement was found in SLC7A9 gene as well as 24 sequence variants including 3 novel variants: c.216C>T (p.C72C), c.1119G>A (p.S373S) and c.*82C>T. In our cohort the most frequent pathogenic mutations were: large rearrangements (33.3% of mutant alleles) and a missense mutation c.1400T>C ( p.M467T) (11.1%). This report expands the spectrum of SLC3A1 and SLC7A9 mutations and provides guidance in the clinical implementation of molecular assays in routine genetic counseling of Portuguese patients affected with Cystinuria.por
dc.identifier.citationClin Genet. 2012 Jan;81(1):47-55. Epub 2011 Feb 14por
dc.identifier.issn0009-9163
dc.identifier.otherdoi: 10.1111/j.1399-0004.2011.01638.x.
dc.identifier.urihttp://hdl.handle.net/10400.18/950
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherJohn Wiley and Sonspor
dc.relation.publisherversionhttp://onlinelibrary.wiley.com/doi/10.1111/j.1399-0004.2011.01638.x/abstract;jsessionid=FF114F2E54DC1E26BEE6349F96F6F2D2.d03t04por
dc.subjectDoenças Genéticaspor
dc.subjectCystinuriapor
dc.subjectMLPA Analysispor
dc.subjectSilent Mutationpor
dc.subjectSLC3A1 genepor
dc.subjectSLC7A9 genepor
dc.titleClinical, biochemical and molecular characterization of cystinuria in a cohort of 12 patients.por
dc.typejournal article
dspace.entity.typePublication
oaire.citation.titleClinical Geneticspor
rcaap.rightsrestrictedAccesspor
rcaap.typearticlepor

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Clinical, biochemical and molecular clinical genetics 2012.pdf
Size:
567.4 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

DGH - Artigos em revistas internacionais